Traditional and emerging cardiovascular risk factors in end-stage renal disease
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 63 (85) , S105-S110
- https://doi.org/10.1046/j.1523-1755.63.s85.25.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patientsKidney International, 2002
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patientsKidney International, 1998
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic PatientsNephrology Dialysis Transplantation, 1991
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Norepinephrine-related mechanism in hypertension accompanying renal failureKidney International, 1985